Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes

NCT02962492 is registered in ClinicalTrials.gov with University at Buffalo as lead sponsor.

NCT NCT02962492
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02962492 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes
Lead sponsor
University at Buffalo
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2016
Completion date
October 24, 2021
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

evaluate ketogenic stress